UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

p53 Nongenotoxic Activation and mTORC1 Inhibition Lead to Effective Combination for Neuroblastoma Therapy

Clinical cancer research, 2017-11, Vol.23 (21), p.6629-6639

2017

Volltextzugriff (PDF)

Histone Chaperone CHAF1A Inhibits Differentiation and Promotes Aggressive Neuroblastoma

Cancer research (Chicago, Ill.), 2014-02, Vol.74 (3), p.765-774

2014

Volltextzugriff (PDF)

MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma

Oncotarget, 2018-04, Vol.9 (29), p.20323-20338

2018

Volltextzugriff (PDF)

A p53 drug response signature identifies prognostic genes in high-risk neuroblastoma

PloS one, 2013-11, Vol.8 (11), p.e79843-e79843

2013

Volltextzugriff (PDF)

A Genome-Wide Search for Promoters That Respond to Increased MYCN Reveals Both New Oncogenic and Tumor Suppressor MicroRNAs Associated with Aggressive Neuroblastoma

Cancer research (Chicago, Ill.), 2011-06, Vol.71 (11), p.3841-3851

2011

Volltextzugriff (PDF)

G-CSF Receptor Positive Neuroblastoma Subpopulations Are Enriched in Chemotherapy-Resistant or Relapsed Tumors and Are Highly Tumorigenic

Cancer research (Chicago, Ill.), 2013-07, Vol.73 (13), p.4134-4146

2013

Volltextzugriff (PDF)

The p53 Regulatory Gene MDM2 Is a Direct Transcriptional Target of MYCN in Neuroblastoma

Proceedings of the National Academy of Sciences - PNAS, 2005-01, Vol.102 (3), p.731-736

2005

Volltextzugriff (PDF)

MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell death

Molecular cancer therapeutics, 2006-09, Vol.5 (9), p.2358-2365

2006

Volltextzugriff (PDF)

Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma

Angiogenesis (London), 2011-09, Vol.14 (3), p.255-266

2011

Volltextzugriff (PDF)

Mdm2 Deficiency Suppresses MYCN-Driven Neuroblastoma Tumorigenesis In Vivo

Neoplasia (New York, N.Y.), 2009-08, Vol.11 (8), p.753-762

2009

Volltextzugriff (PDF)

MYCN-directed centrosome amplification requires MDM2-mediated suppression of p53 activity in neuroblastoma cells

Cancer research (Chicago, Ill.), 2007-03, Vol.67 (6), p.2448-2455

2007

Volltextzugriff (PDF)

G-CSF Promotes Neuroblastoma Tumorigenicity and Metastasis via STAT3-Dependent Cancer Stem Cell Activation

Cancer research (Chicago, Ill.), 2015-06, Vol.75 (12), p.2566-2579

2015

Volltextzugriff (PDF)

Divergent structures of Mammalian and gammaherpesvirus uracil DNA glycosylases confer distinct DNA binding and substrate activity

DNA repair, 2023-08, Vol.128, p.103515-103515, Article 103515

2023

Volltextzugriff (PDF)

Isolation and characterization of a novel GCSF responsive, highly tumorigenic subpopulation in neuroblastoma

Journal of the American College of Surgeons, 2010, Vol.211 (3), p.S69-S69

2010

Volltextzugriff (PDF)

Abstract A15: Epigenetic regulators maintain neuroblastoma cancer stem cells: Model to treatment

Cancer research (Chicago, Ill.), 2016-03, Vol.76 (5_Supplement), p.A15-A15

2016

Volltextzugriff (PDF)

Uracil DNA Glycosylase of Gammaherpesvirus alters somatic hypermutation through error-free DNA repair

The Journal of immunology (1950), 2018-05, Vol.200 (1_Supplement), p.48-48.12

2018

Volltextzugriff (PDF)

Abstract 4781: Epigenetic regulation of neuroblastoma tumorigenicity through MLL1 and JMJD3 modulation in cancer stem cells

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.4781-4781

2017

Volltextzugriff (PDF)

Abstract A02: The epigenetic modifier CHAF1A opposes neuroblastoma differentiation via metabolic reprogramming

Molecular cancer research, 2015-10, Vol.13 (10_Supplement), p.A02-A02

2015

Volltextzugriff (PDF)

Abstract B44: The epigenetic modifier CHAF1A opposes neuroblastoma differentiation via metabolic reprogramming

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (20_Supplement), p.B44-B44

2014

Volltextzugriff (PDF)

Abstract A59: CHAF1A blocks neuroblastoma differentiation and promotes tumor growth via metabolic reprogramming

Molecular cancer research, 2016-01, Vol.14 (1_Supplement), p.A59-A59

2016

Volltextzugriff (PDF)

Transmembrane adaptor protein PAG1 is a novel tumor suppressor in neuroblastoma

Oncotarget, 2016-04, Vol.7 (17), p.24018-24026

2016

Volltextzugriff (PDF)

Correction: MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma

Oncotarget, 2018-07, Vol.9 (52), p.30024-30024

2018

Volltextzugriff (PDF)

Abstract B58: The novel MDM2 inhibitor RG7388 is highly effective against neuroblastoma in vitro and in vivo

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (20_Supplement), p.B58-B58

2014

Volltextzugriff (PDF)

Abstract 3744: G-CSF-dependent regulation of STAT3 in neuroblastoma cancer stem cell subpopulations

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.3744-3744

2013

Volltextzugriff (PDF)

Abstract 2291: Oncogenic hsa-miR-1323 down-regulates MYCN/ALK and reveals PAG1 as a novel tumor suppressor for neuroblastoma

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.2291-2291

2012

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(40)

Sprache

Englisch
(39)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Life Sciences & Biomedicine
(18)
Humans
(17)
Animals
(12)
Mice
(11)
Oncology
(11)
Neuroblastoma - Metabolism
(10)
Cell Line, Tumor
(8)
Female
(8)
Neuroblastoma
(8)
Neuroblastoma - Pathology
(8)
Tumors
(8)
Apoptosis
(6)
Neuroblastoma - Genetics
(6)
Biological And Medical Sciences
(5)
Gene Expression Regulation, Neoplastic
(5)
Medical Sciences
(5)
N-Myc Proto-Oncogene Protein
(5)
Surgery
(5)
Tumor Suppressor Protein P53 - Genetics
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(12)
Bmc Ophthalmology
(3)
Oncotarget
(3)
Journal Of The American College Of Surgeons
(2)
Molecular Cancer Research
(2)
Neoplasia
(2)
Plos One
(2)
Acs Nano
(1)
Angiogenesis
(1)
Bmc Immunology
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

p53 Nongenotoxic Activation and mTORC1 Inhibition Lead to Effective Combination for Neuroblastoma Therapy

Histone Chaperone CHAF1A Inhibits Differentiation and Promotes Aggressive Neuroblastoma

MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma

A p53 drug response signature identifies prognostic genes in high-risk neuroblastoma

A Genome-Wide Search for Promoters That Respond to Increased MYCN Reveals Both New Oncogenic and Tumor Suppressor MicroRNAs Associated with Aggressive Neuroblastoma

G-CSF Receptor Positive Neuroblastoma Subpopulations Are Enriched in Chemotherapy-Resistant or Relapsed Tumors and Are Highly Tumorigenic

The p53 Regulatory Gene MDM2 Is a Direct Transcriptional Target of MYCN in Neuroblastoma

MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell death

Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma

Mdm2 Deficiency Suppresses MYCN-Driven Neuroblastoma Tumorigenesis In Vivo

MYCN-directed centrosome amplification requires MDM2-mediated suppression of p53 activity in neuroblastoma cells

G-CSF Promotes Neuroblastoma Tumorigenicity and Metastasis via STAT3-Dependent Cancer Stem Cell Activation

Divergent structures of Mammalian and gammaherpesvirus uracil DNA glycosylases confer distinct DNA binding and substrate activity

Isolation and characterization of a novel GCSF responsive, highly tumorigenic subpopulation in neuroblastoma

Abstract A15: Epigenetic regulators maintain neuroblastoma cancer stem cells: Model to treatment

Uracil DNA Glycosylase of Gammaherpesvirus alters somatic hypermutation through error-free DNA repair

Abstract 4781: Epigenetic regulation of neuroblastoma tumorigenicity through MLL1 and JMJD3 modulation in cancer stem cells

Abstract A02: The epigenetic modifier CHAF1A opposes neuroblastoma differentiation via metabolic reprogramming

Abstract B44: The epigenetic modifier CHAF1A opposes neuroblastoma differentiation via metabolic reprogramming

Abstract A59: CHAF1A blocks neuroblastoma differentiation and promotes tumor growth via metabolic reprogramming

Transmembrane adaptor protein PAG1 is a novel tumor suppressor in neuroblastoma

Correction: MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma

Abstract B58: The novel MDM2 inhibitor RG7388 is highly effective against neuroblastoma in vitro and in vivo

Abstract 3744: G-CSF-dependent regulation of STAT3 in neuroblastoma cancer stem cell subpopulations

Abstract 2291: Oncogenic hsa-miR-1323 down-regulates MYCN/ALK and reveals PAG1 as a novel tumor suppressor for neuroblastoma

Suchergebnisse filtern